Newsletter | 01 July 2001 Access News 5, Focus on the Access Campaign, July 2001 INTELLECTUAL PROPERTY AND TRADE The Access Campaign and its different focuses are addressed in this edition of AccessNews. Drug pricing, ARV care, South Africa's victory for the developing world, sleeping sickness and malaria are these editions highlights. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Press release | 26 June 2002 HIV/AIDS Intellectual property and trade New survey gives poor countries information on more affordable AIDS drugs Opinion article | 24 June 2002 Intellectual property and trade Why Article 30 will work. Why Article 31 will not. 3 min Research article | 22 June 2002 Intellectual property and trade Drug development for neglected diseases: a deficient market and a public-health policy failure 2 min Press release | 21 June 2002 Intellectual property and trade Tropical & neglected diseases New drug for visceral leishmaniasis is first step in tackling neglected diseases but much more must be done Press release | 29 May 2002 HIV/AIDS Intellectual property and trade Zimbabwe Zimbabwe government takes emergency action against HIV/AIDS Press release | 24 May 2002 HIV/AIDS Intellectual property and trade Ukraine MSF and Ukrainian NGO criticise Ukrainian HIV/Aids deal Research article | 05 May 2002 Intellectual property and trade Brazil Lancet: Access to Antiretroviral Drugs in Brazil 1 min Letter | 01 May 2002 Intellectual property and trade MSF comments on the Draft Free Trade Area of the Americas (FTAA) Agreement 11 min Load More
Press release | 26 June 2002 HIV/AIDS Intellectual property and trade New survey gives poor countries information on more affordable AIDS drugs
Opinion article | 24 June 2002 Intellectual property and trade Why Article 30 will work. Why Article 31 will not. 3 min
Research article | 22 June 2002 Intellectual property and trade Drug development for neglected diseases: a deficient market and a public-health policy failure 2 min
Press release | 21 June 2002 Intellectual property and trade Tropical & neglected diseases New drug for visceral leishmaniasis is first step in tackling neglected diseases but much more must be done
Press release | 29 May 2002 HIV/AIDS Intellectual property and trade Zimbabwe Zimbabwe government takes emergency action against HIV/AIDS
Press release | 24 May 2002 HIV/AIDS Intellectual property and trade Ukraine MSF and Ukrainian NGO criticise Ukrainian HIV/Aids deal
Research article | 05 May 2002 Intellectual property and trade Brazil Lancet: Access to Antiretroviral Drugs in Brazil 1 min
Letter | 01 May 2002 Intellectual property and trade MSF comments on the Draft Free Trade Area of the Americas (FTAA) Agreement 11 min
